Document is current
Any future updates will be listed below
-
Authors
Agholme, Jonas
Ahtola, Kim
Toll, Ebba
Carlhäll, Carl-Johan
Henriksson, Pontus
Kechagias, Stergios
Lundberg, Peter
Nasr, Patrik
Sysoev, Oleg
Wijkman, Magnus
Ekstedt, Mattias
Ulander, Martin
Iredahl, Fredrik https://orcid.org/0000-0002-4245-7565
-
Funding
Funding for this research was provided by:
Linköping University
- License Information
-
More Information
Article History
Received: 30 September 2024
Accepted: 6 March 2025
First Online: 13 March 2025
Change Date: 14 July 2025
Change Type: Update
Change Details: This article has been updated to amend the license information.
Declarations
:
: JA has received speaker fees from AstraZeneca. MW has served on advisory boards or lectured for MSD, Lilly, Novo Nordisk, and Sanofi, and organized a professional regional meeting sponsored by Lilly, Rubin Medical, Sanofi, Novartis, and Novo Nordisk. ME has served on advisory boards for AMRA Medical and Novo Nordisk. FI has received speaker fees and served on advisory boards for Novo Nordisk, Sanofi, and Boehringer Ingelheim. All other authors declare no competing interests.
